Full Text (PDF)
Original Article

Evaluating the Adjuvant Effect of Dexamethasone to Ropivacainein Transversus Abdominis Plane Block for Inguinal Hernia Repair

Ekta Patel, Parth Shah, Bansari Shah, Bipin M Patel

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Indian Journal of Anesthesia and Analgesia 11(3):p 129-134, July- September 2024. | DOI: 10.21088/ijaa.2349.8471.11324.2

How Cite This Article:

Patel E, Shah P, Shah B, et al. Evaluating the adjuvant effect of dexamethasone to ropivacaine in transversus abdominis plane block for inguinal hernia repair. Ind J Anesth Analg. 2024;11(3):129-34.

Timeline

Received : April 13, 2023         Accepted : June 22, 2024          Published : September 28, 2024

Abstract

Background: The transversus abdominis plane (TAP) block serves as a straightforward regional technique employed to alleviate postoperative pain in patients undergoing abdominal surgeries. Over the years, various additives have been utilized to prolong the analgesic effects of peripheral nerve blocks. Several studies have investigated the effectiveness of adding dexamethasone to local anesthetics such as bupivacaine, with promising results. However, there is still a lack of studies directly comparing the efficacy of dexamethasone when combined with ropivacaine. Objectives: To investigate whether combining dexamethasone 8 mg with ropivacaine 0.2% in a TAP block would result in a prolonged analgesic effect compared to using ropivacaine 0.2% alone following inguinal hernia repair. Study Design: A prospective study conducted in a teaching hospital, utilizing a randomized, double-blinded and placebo-controlled design. Methods: The study enrolled a total of 62 patients undergoing either inguinal hernia repair. Among them, 31 patients were administered a TAP block with ropivacaine combined with saline, while the remaining 31 received ropivacaine with dexamethasone immediately after the surgery. Both the proceduralist (resident) and the patient were kept unaware of the solution used. Pain levels were assessed using visual analog pain scores (ranging from 0 to 10) before and immediately after the block. Our main focus was the visual analog pain score at the 12-hour mark, with pain scores at 24 and 48 hours serving as secondary endpoints. Results: In the saline group, the average pre-block pain score was 7.8 ± 1.8 while in the dexamethasone group, it was 7.9 ± 2.3. Both groups experienced an improvement in pain scores compared to baseline at 12 hours post-block administration. Although the dexamethasone group exhibited a greater reduction in pain score (-3.2) compared to the saline group (-2.2), this discrepancy between the two groups did not reach statistical signifcance (p = 0.08). Furthermore, there were no significant variances in the change from baseline observed at 24 and 48 hours between the two groups (p values = 0.74 and 0.44, respectively). Limitations: We opted not to evaluate the cumulative dose of analgesics administered during surgery under the assumption that the impact of intraoperative analgesia would diminish by the time we assessed the 12-hour pain score. We also did not standardize for the proficiency of the block provider, considering that certain providers might have been junior residents lacking extensive experience in this domain. Furthermore, we couldn’t incorporate postoperative opioid consumption due to concerns regarding potential disparities in patient reporting and data reliability. Conclusion: In summary, our study did not demonstrate a statistically significant extension of analgesia for TAP blocks with ropivacaine when dexamethasone was included. However, there was a notable one-point reduction in pain scores at 12 hours following the addition of dexamethasone to the block solution. Despite the absence of statistical significance, this reduction in pain scores at the 12-hour mark could still contribute to enhanced patient satisfaction, especially considering the favorable side effect profile of dexamethasone. Given that ropivacaine has a lower pH compared to other local anesthetic agents, further well-designed studies are warranted to explore its combination with more alkaline drugs such as corticosteroids.


References

  • 1.   Carney J, McDonnell JG, Ochana A. The transversus abdominis plane block pro-vides effectivepo stoperativeanalgesiain patients undergoing total abdomi-nal hysterectomy. Anesth Analg 2008;107:2056-2060.
  • 2.   McDonnellJG,O’DonnellBD,FarrellT,Gough N, Tuite D, Power C, Laffey JG.Transversus abdominis plane block:Aca-daveric and radiological evaluation. RegAnesthPainMed2007;32:399-404.
  • 3.   Bonnet F, Berger J, Aveline C. Transver-sus abdominis plane block: What is itsrole in postoperative analgesia? Br J An-aesth2009;103:468-470.
  • 4.   McDonnell JG, O’Donnell B, Curley G,Heffernan A, Power C, Laffey JG. The analgesic efficacy of transversus abdominisplane block after abdominal surgery: Aprospectiverandomized controlledtrial. Anesth Analg2007; 104:193-197.
  • 5.   Tan TT, Teoh WH, Woo DC, OcampoCE, Shah MK, Sia AT. A randomised tri-al of the analgesic efficacy of ultra sound-guided transversus abdominis plane block after caesarean delivery undergen-eral anaesthesia. Eur J Anaesthesiol 2012;29:88-94.
  • 6.   Shin SJ, Kim ST, Yim KH, Hyun Su Lee1,Sim JH, Shin YD. Preemptive analgesicefficacy of ultrasoundguided transver-sus abdominis plane block in patientsundergoing gynecologic surgery via atransverse lower abdominal skin inci-sion. Korean J Anesthesiol 2011; 61:413-418.
  • 7.   McDonnell JG, Curley G, Carney J, Ben-ton A, Costello J, Maharaj CH, Laffey JG.The analgesic efficacy of transversus ab-dominis plane block after cesarean deliv-ery: A randomized controlled trial. Anesth Analg2008;106:186-191.
  • 8.   O’DonnellBD,McDonnellJG,McShaneAJ. The transversus abdominis plane (TAP) block in open retropubic prostatec-tomy. Reg Anesth Pain Med 2006;31:91.
  • 9.   Niraj G, Searle A, Mathews M. Analge-sicefficacy of ultrasound-guided trans-versus abdominis plane block in patients undergoing open appendicectomy. Br JAnaesth2009;103:601-605.
  • 10.   Kartalov A, Jankulovski N, Kuzmanovs-ka B, Zdravkovska M. Effect of addingdexamethasone as a ropivacaine adju-vant in ultrasound-guided transversusabdominis plane block for inguinal her-nia repair. Pril (Makedon Akad Nauk UmetOdd MedNauki)2015;36:35-41.
  • 11.   Webb BG, Sallay PI, McMurray SD, Mis-amore GW. Comparison of interscalenebrachial plexus block performed withand without steroids. Orthopedics 2016;doi:10.3928/01477447-20160819-02.
  • 12.   Ammar AS, Mahmoud KM. Effect of adding dexamethasonetobupivacaineon transversus abdominis plane block for abdominal hysterectomy: A prospective randomized controlled trial. Saudi JAnaesth2012;6:229-233.
  • 13.   Hwang H, Park J, Lee WK, Lee WH, Leigh JH, Lee JJ, Chung SG, Lim C, ParkSJ, KimK. Crystallization of localanes-thetics when mixed with corticosteroid solutions. Ann Rehabil Med 2016; 40:21-27.
  • 14.   Watkins TW, Dupre S, Coucher JR. Rop-ivacaine and dexamethasone: A poten-tially dangerous combination for thera-peuticpaininjections. JMedImagingRa-diatOncol 2015;59:571-577.

Data Sharing Statement

There are no additional data available.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

Information not provided.

Conflicts of Interest

The authors report no conflicts of interest in this work.


About this article


Cite this article

Patel E, Shah P, Shah B, et al. Evaluating the adjuvant effect of dexamethasone to ropivacaine in transversus abdominis plane block for inguinal hernia repair. Ind J Anesth Analg. 2024;11(3):129-34.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
April 13, 2023 June 22, 2024 September 28, 2024

DOI: 10.21088/ijaa.2349.8471.11324.2

Keywords

Adjuvant dexamethasoneRopivacaine hydrochlorideTransverse Abdominis Plane

Article Level Metrics

Last Updated

Saturday 07 February 2026, 21:06:28 (IST)


1189

Accesses

4
194
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received April 13, 2023
Accepted June 22, 2024
Published September 28, 2024

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share